BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16643769)

  • 21. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients.
    da Silva LM; Guimarães AL; Victória JM; Gomes CC; Gomez RS
    Oral Dis; 2005 Jan; 11(1):13-6. PubMed ID: 15641961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The controversial natural history of oral herpes simplex virus type 1 infection.
    Petti S; Lodi G
    Oral Dis; 2019 Nov; 25(8):1850-1865. PubMed ID: 31733122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycoprotein D adjuvant herpes simplex virus vaccine.
    Bernstein D
    Expert Rev Vaccines; 2005 Oct; 4(5):615-27. PubMed ID: 16221064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes simplex virus infections in neonates and early childhood.
    Kimberlin DW
    Semin Pediatr Infect Dis; 2005 Oct; 16(4):271-81. PubMed ID: 16210107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunity in latent Herpes simplex virus infection.
    Bystrická M; Russ G
    Acta Virol; 2005; 49(3):159-67. PubMed ID: 16178513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cellular response to herpes simplex virus type 1 (HSV-1) during latency and reactivation.
    Kent JR; Fraser NW
    J Neurovirol; 2005 Aug; 11(4):376-83. PubMed ID: 16162480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are all aciclovir cream formulations bioequivalent?
    Trottet L; Owen H; Holme P; Heylings J; Collin IP; Breen AP; Siyad MN; Nandra RS; Davis AF
    Int J Pharm; 2005 Nov; 304(1-2):63-71. PubMed ID: 16139970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
    Bernstein DI; Spruance SL; Arora SS; Schroeder JL; Meng TC
    Clin Infect Dis; 2005 Sep; 41(6):808-14. PubMed ID: 16107978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection, quantification and genotyping of Herpes Simplex Virus in cervicovaginal secretions by real-time PCR: a cross sectional survey.
    Aryee EA; Bailey RL; Natividad-Sancho A; Kaye S; Holland MJ
    Virol J; 2005 Aug; 2():61. PubMed ID: 16095535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olfactory transmission of neurotropic viruses.
    Mori I; Nishiyama Y; Yokochi T; Kimura Y
    J Neurovirol; 2005 Apr; 11(2):129-37. PubMed ID: 16036791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment.
    Miller CS; Avdiushko SA; Kryscio RJ; Danaher RJ; Jacob RJ
    J Clin Microbiol; 2005 May; 43(5):2173-80. PubMed ID: 15872238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2.
    Namvar L; Olofsson S; Bergström T; Lindh M
    J Clin Microbiol; 2005 May; 43(5):2058-64. PubMed ID: 15872222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advances in antiviral therapy.
    Wu JJ; Pang KR; Huang DB; Tyring SK
    Dermatol Clin; 2005 Apr; 23(2):313-22. PubMed ID: 15837157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agents and strategies in development for improved management of herpes simplex virus infection and disease.
    Kleymann G
    Expert Opin Investig Drugs; 2005 Feb; 14(2):135-61. PubMed ID: 15757392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bell's palsy and Herpes simplex virus: fact or mystery?
    Linder T; Bossart W; Bodmer D
    Otol Neurotol; 2005 Jan; 26(1):109-13. PubMed ID: 15699730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994.
    Schillinger JA; Xu F; Sternberg MR; Armstrong GL; Lee FK; Nahmias AJ; McQuillan GM; Louis ME; Markowitz LE
    Sex Transm Dis; 2004 Dec; 31(12):753-60. PubMed ID: 15608591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence of viremia in patients with primary herpetic gingivostomatitis.
    Harel L; Smetana Z; Prais D; Book M; Alkin M; Supaev E; Mendelson E; Amir J
    Clin Infect Dis; 2004 Sep; 39(5):636-40. PubMed ID: 15356775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
    Tyler KL
    Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic options for herpes labialis, II: Topical agents.
    Elish D; Singh F; Weinberg JM
    Cutis; 2004 Jul; 74(1):35-40. PubMed ID: 15293698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.